Prosecution Insights
Last updated: October 25, 2026
Application No. 19/026,219

PATIENT-SPECIFIC EXPANDABLE SPINAL IMPLANTS AND ASSOCIATED SYSTEMS AND METHODS

Non-Final OA §103
Filed
Jan 16, 2025
Priority
Jun 08, 2021 — provisional 63/208,084 +1 more
Examiner
BAYAT, ALI
Art Unit
2677
Tech Center
2600 — Communications
Assignee
Carlsmed Inc.
OA Round
1 (Non-Final)
92%
Grant Probability
Favorable
1-2
OA Rounds
4m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 92% — above average
92%
Career Allowance Rate
958 granted / 1037 resolved
+30.4% vs TC avg
Moderate +6% lift
Without
With
+5.9%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
8 currently pending
Career history
1051
Total Applications
across all art units

Statute-Specific Performance

§101
19.9%
-20.1% vs TC avg
§103
28.0%
-12.0% vs TC avg
§102
21.0%
-19.0% vs TC avg
§112
16.5%
-23.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1037 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 1. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 40-42 and 44 are rejected under 35 U.S.C. 103 as being unpatentable over BIRD et al. US 20230094575 (hereinafter Bird) in view of Frey et al. US 20140350614(hereinafter Frey). Regarding claim 40, Bird provides for obtaining patient data including image data of one or more regions of a patient's spine in a native anatomical configuration ( [0085] Method 1200 includes measuring a patient for a spinal implant to determine one or more measurements, at 1210. For example, a computer or health care professional may image a patient's spine to determine a measurement or may read a previously acquired image”); determining a target anatomical configuration for the one or more regions, wherein the target anatomical configuration is different than the native anatomical configuration ( see [0085], see “ To illustrate, an X-ray or CT image may be used to determine a spinal implant dimension, such as a vertebral spacing or thickness”); and designing a plurality of separately implantable patient-specific devices that cooperate to achieve the target anatomical configuration (see “[0086] Method 1200 also includes modifying at least one base dimension of the spinal implant based on the one or more measurements, at 1212”). Bird does not provide for, wherein at least one of the implantable patient-specific devices is expandable to position the patient's spine in the target anatomical configuration. Frey teaches the above missing limitation of Bird, see [0233] of Frey see “ In the context of a spinal implant, the implant may further specify a desired angle of lordosis or coronal defect correction, specify a patient-specific height of the implant or (desired height following disc height restoration), specify a degree of expansion permitted (for expandable implants), and may be unidirectional or multi-directional depending on the surgery and the surgeon preference”). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention, to combine the teaching of Frey with the system and method of Bird, in order to obtain the claimed invention, via the expandable implants, a finding that one of ordinary skill in the art would have recognized that the results of the combination were predictable (MPEP 2143). Regarding claim 41, Bird does provide for, wherein the at least one implantable patient-specific devices is an expandable interbody device and another of the patient-specific devices is a fusion rod system([0056], see “For example, the fasteners 146 may include screws, pins, rods”, further see [0059] “ spinal implant 102 may enable better and quicker fusion of the spinal implant and reduce non-union and subsidence”). Regarding claim 42, Bird does not provide for, wherein the target anatomical configuration includes restoration disk heights at multiple levels along the patient's spine, wherein the at least one of the implantable patient-specific devices are designed to achieve the restoration disk heights. Frey teaches the above missing limitation of Bird, see [0233] of Frey see “ In the context of a spinal implant, the implant may further specify a desired angle of lordosis or coronal defect correction, specify a patient-specific height of the implant or (desired height following disc height restoration), specify a degree of expansion permitted (for expandable implants), and may be unidirectional or multi-directional depending on the surgery and the surgeon preference”). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention, to combine the teaching of Frey with the system and method of Bird, in order to obtain the claimed invention, via the expandable implants, a finding that one of ordinary skill in the art would have recognized that the results of the combination were predictable (MPEP 2143). Regarding claim 44, Bird does not provide for, wherein the target anatomical configuration includes one or more target disk heights and an acceptable spinal curvature of the spine. Frey teaches the above missing limitation of Bird, see [0233] of Frey see “ In the context of a spinal implant, the implant may further specify a desired angle of lordosis or coronal defect correction, specify a patient-specific height of the implant or (desired height following disc height restoration), specify a degree of expansion permitted (for expandable implants), further see [0311] of Frey teaches “the plurality of guides may receive a plurality of elongated shafts or "indicators" to assist the user in visualizing the location, orientation, curvature and/or deformity associated with the patient's underlying anatomy”). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention, to combine the teaching of Frey with the system and method of Bird, in order to obtain the claimed invention, via the expandable implants and "indicators" to assist the user in visualizing the location, orientation, curvature and/or deformity associated with the patient's underlying anatomy , a finding that one of ordinary skill in the art would have recognized that the results of the combination were predictable (MPEP 2143). Allowable Subject Matter 2. Claim 43 is objected to as being dependent upon a rejected base claim but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Reasons for Allowance The following is an examiner’s statement of reasons for allowance: the prior arts of over BIRD et al. US 20230094575 in view of Frey et al. US 20140350614, either alone or combined failed to teach or suggest for designing auxiliary implantable devices based on the target anatomical configuration achieved by the plurality of interbody devices. As cited in claim 43. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Allowed Claims 3. Claims 30-39 are allowed. Reasons for Allowance The following is an examiner’s statement of reasons for allowance: the prior arts of over BIRD et al. US 20230094575 in view of Frey et al. US 20140350614, either alone or combined failed to teach or suggest for determining a treatment plan for a target spinal correction of the patient's spine based on the obtained patient data, the target spinal correction including increasing a spacing between adjacent vertebral bodies; and designing an expandable interbody device according to the treatment plan such that the expandable interbody device (i) has a topological feature configured to the identified at least one anatomical feature, and (ii) is transitionable between a collapsed configuration and an expanded configuration, wherein the dimensions of the device in the expanded configuration are set to induce the increased spacing associated with the target spinal correction. As cited in independent claim 30. Further the prior arts of over BIRD et al. US 20230094575 in view of Frey et al. US 20140350614, either alone or combined failed to teach or suggest for “designing an adjustable patient-specific implant based at least in part on the target anatomical configuration and the topography of the inferior surface, wherein, when the adjustable patient-specific implant is implanted in the patient, the patient-specific implant is configured to be adjusted to bias the patient's spine toward the target anatomical configuration”. As cited in independent claim 34. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Ali US 2 0190117266, is cited because the reference teaches “[0009] According to some embodiments, the passage created through the first vertebra is generally linear. In some embodiments, the method is performed minimally invasively. In some embodiments, the implant comprises an expandable implant (e.g., a coiled implant, an inflatable implant, etc.). Sungarian et al. US 20130158669, is cited because the reference teaches “Such implants are used to correct degenerative conditions and facilitate spinal fusion while stabilizing and strengthening the spine. Spinal fusion is the joining of adjacent vertebrae through shared bone”, in [0006]. Butler et al. US 8444697 is cited because the reference teaches “The mass of the moveable block(s) forces the hinged top(s) of the interbody spacer to expand upward. Similarly, the hinged bottom expand downwards. The upward expansion of the hinged top and, or downward expansion of the hinged bottom will force the adjacent vertebra to move. The expansion of the hinged top(s) and, or bottom may be used to restore normal balance, tilt and disc height of the vertebrae. See summery. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALI BAYAT whose telephone number is (571)272-7444. The examiner can normally be reached 9:00-5:00 M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Andrew Bee can be reached at 571-2705183. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALI BAYAT/ Primary Examiner, Art Unit 2677
Read full office action

Prosecution Timeline

Jan 16, 2025
Application Filed
Oct 06, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740725
METHOD AND APPARATUS FOR DETECTING STEREOTYPED BEHAVIOR TO SUPPORT DIAGNOSIS OF AUTISM SPECTRUM DISORDER
2y 4m to grant Granted Sep 22, 2026
Patent 12744989
INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, PROGRAM, AND INFORMATION PROCESSING SYSTEM
2y 6m to grant Granted Sep 22, 2026
Patent 12737890
INFORMATION PROCESSING APPARATUS, NON-TRANSITORY COMPUTER READABLE MEDIUM, AND INFORMATION PROCESSING METHOD
3y 6m to grant Granted Sep 15, 2026
Patent 12731292
METHOD OF LEARNING PARAMETER OF SENSOR FILTER AND APPARATUS FOR PERFORMING THE SAME
3y 4m to grant Granted Sep 08, 2026
Patent 12731693
DEEP LEARNING-BASED CANCER PROGNOSIS SURVIVAL PREDICTION METHOD AND DEVICE, AND STORAGE MEDIUM
2y 8m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
92%
Grant Probability
98%
With Interview (+5.9%)
2y 1m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1037 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month